Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 32 - Issue 5 - May, 2020

Feature

Temporal Trends and Outcomes of Percutaneous Coronary Atherectomy in the United States
Original Contribution
Temporal Trends and Outcomes of Percutaneous Coronary Atherectomy in the United States
04/29/2020

Ayman Elbadawi, MD1; Mohammed Elzeneini, MD2; Islam Y. Elgendy, MD3; Karim Mahmoud, MD4; Mohmed A. Omer, MD5; Gbolahan O. Ogunbayo, MD6; Waleed Kayani, MD7; Ali Denktas, MD7; David Paniagua, MD7; Hani Jneid, MD7

Ayman Elbadawi, MD1; Mohammed Elzenei...
Coronary plaque modification via coronary atherectomy has evolved dramatically since its introduction as an important adjunct to PCI in the subset of patients with complex plaques.
Coronary plaque modification via coronary atherectomy has evolved dramatically since its introduction as an important adjunct to PCI in the subset of patients with complex plaques.
Coronary plaque modification via...
04/29/2020
Journal of Invasive Cardiology
Safety and Long-Term Patency of Endovascular Therapy for Infrarenal Aortic Disease: Single-Center Experience and Review of the Literature
Vascular Disease
Safety and Long-Term Patency of Endovascular Therapy for Infrarenal Aortic Disease: Single-Center Experience and Review of the Literature
04/29/2020

Muhammad Asif Mangi, MD; Chandramohan Meenakshisundaram, MD; Mubbasher Ameer Syed, MD; 
Khalid Hamid Changal, MD; Mohammed Alyosif, MD; Mark W. Burket, MD; Mujeeb A. Sheikh, MD

Muhammad Asif Mangi, MD; Chandramohan...
Endovascular therapy (EVT) has emerged as an alternative to surgery for the treatment of symptomatic infrarenal aortic stenosis. However, long-term outcomes with EVT are unknown. We performed a retrospective review of infrarenal aortic...
Endovascular therapy (EVT) has emerged as an alternative to surgery for the treatment of symptomatic infrarenal aortic stenosis. However, long-term outcomes with EVT are unknown. We performed a retrospective review of infrarenal aortic...
Endovascular therapy (EVT) has...
04/29/2020
Journal of Invasive Cardiology
Instantaneous Wave-Free Ratio (iFR) Correlates With Fractional Flow Reserve (FFR) Assessment of Coronary Artery Stenoses and Myocardial Bridges in Children
Original Contribution
Instantaneous Wave-Free Ratio (iFR) Correlates With Fractional Flow Reserve (FFR) Assessment of Coronary Artery Stenoses and Myocardial Bridges in Children
04/29/2020

Tam T. Doan, MD, MS1; James C. Wilkinson, MD1; Hitesh Agrawal, MD2; Silvana Molossi, MD, PhD1; Mahboob Alam, MD3; Carlos M. Mery, MD, MPH4; Athar M. Qureshi, MD1

Tam T. Doan, MD, MS1; James C. Wilkin...
Instantaneous wave-free ratio (iFR) has been proven to correlate with coronary flow reserve better than fractional flow reserve (FFR) and is non-inferior to FFR in guiding coronary revascularization in ischemic heart disease. There has been...
Instantaneous wave-free ratio (iFR) has been proven to correlate with coronary flow reserve better than fractional flow reserve (FFR) and is non-inferior to FFR in guiding coronary revascularization in ischemic heart disease. There has been...
Instantaneous wave-free ratio...
04/29/2020
Journal of Invasive Cardiology
Randomized Trial of Radial Hemostasis Using Focused vs Balloon Compression Devices
Original Contribution
Randomized Trial of Radial Hemostasis Using Focused vs Balloon Compression Devices
04/23/2020

Jordan G. Safirstein, MD1;  Ali Elfandi, MD1;  Nicole Reid, MD1;  Timothy W.I. Clark, MD2

Jordan G. Safirstein, MD1;  Ali Elfan...
Radial artery hemostasis devices differ in compression mechanisms, which may influence time to hemostasis and hand perfusion.
Radial artery hemostasis devices differ in compression mechanisms, which may influence time to hemostasis and hand perfusion.
Radial artery hemostasis devices...
04/23/2020
Journal of Invasive Cardiology
Transcatheter Valve Implantation for Failed Surgical Aortic and Mitral Bioprostheses: A Single-Center Experience
Original Contribution
Transcatheter Valve Implantation for Failed Surgical Aortic and Mitral Bioprostheses: A Single-Center Experience
03/10/2020

Jerry Lipinski, MD1*; Sandeep M. Patel, MD2*; Toral R. Patel, MD3; Daniel Kobe, MD3, Petar Saric, MD, PharmD3; Muhammad Panhwar, MD3; Fahd Nadeem, MD4; Jun Li, MD4; Joshua R. Clevenger, MD4; Yasuhiro Ichibori, MD4; Anas Fares, MD4; Katherine Lang, BA5; Hiram G. Bezerra, MD, PhD4; Basar Sareyyupoglu, MD6; Benjamin Medalion, MD4; Salil Deo, MD4; Yakov Elgudin, MD, PhD4; Alan Markowitz, MD4; Daniel I. Simon, MD4; Marco A. Costa, MD, PhD4; Ankur Kalra, MD4; Guilherme F. Attizzani, MD4

Jerry Lipinski, MD1*; Sandeep M. Pate...
We share our center’s experience with the use of transcatheter valvular therapies in the setting of failed bioprostheses.
We share our center’s experience with the use of transcatheter valvular therapies in the setting of failed bioprostheses.
We share our center’s experience...
03/10/2020
Journal of Invasive Cardiology
Impact of Left Ventricular Outflow Tract Calcification on Pacemaker Implantation After Transcatheter Aortic Valve Implantation With Second-Generation Devices
Original Contribution
Impact of Left Ventricular Outflow Tract Calcification on Pacemaker Implantation After Transcatheter Aortic Valve Implantation With Second-Generation Devices
02/10/2020

Marco B. Ancona, MD1;  Francesco Moroni, MD1;  Matteo Pagnesi, MD1;  Paolo Del Sole, MD1;  Ozan Demir, MD1;  Saud Khawaja, MD1;  Barbara Bellini, MD1;  Luca Ferri, MD1;  Alessandro Beneduce, MD1;  Emanuele Visco, MD1; Cristina Capogrosso, MD2;  Eustachio Agricola, MD2;  Antonio Esposito, MD3;  Anna Palmisano, MD3; Alaide Chieffo, MD1;  Matteo Montorfano, MD1  

Marco B. Ancona, MD1;  Francesco Moro...
Abstract: Objectives. To evaluate the impact of left ventricular outflow tract calcification (LVOT-CA) localization and extension on permanent pacemaker implantation (PPI) rates after transcatheter aortic valve implantation (TAVI) with...
Abstract: Objectives. To evaluate the impact of left ventricular outflow tract calcification (LVOT-CA) localization and extension on permanent pacemaker implantation (PPI) rates after transcatheter aortic valve implantation (TAVI) with...
Abstract: Objectives. To...
02/10/2020
Journal of Invasive Cardiology
Use of Polymer-Jacketed, Tapered-Tip, Low-Force Guidewires With Composite-Core, Dual-Coil Design as Part of the Antegrade Approach to Coronary Chronic Total Occlusions
Use of Polymer-Jacketed, Tapered-Tip, Low-Force Guidewires With Composite-Core, Dual-Coil Design as Part of the Antegrade Approach to Coronary Chronic Total Occlusions
04/29/2020

Jeffrey E. Rossi, MD;  Ravi Nair, MD;  Stephen G. Ellis, MD;  Samir R. Kapadia, MD;  Jaikirshan J. Khatri, MD

Jeffrey E. Rossi, MD;  Ravi Nair, MD;...
We investigate the impact of Fielder XT-R and XT-A (Asahi Intecc) on antegrade wire escalation (AWE) crossing of Coronary CTO lesions. A total of 164 consecutive CTO lesions were treated with a primary AWE strategy using either guide wire as...
We investigate the impact of Fielder XT-R and XT-A (Asahi Intecc) on antegrade wire escalation (AWE) crossing of Coronary CTO lesions. A total of 164 consecutive CTO lesions were treated with a primary AWE strategy using either guide wire as...
We investigate the impact of...
04/29/2020
Journal of Invasive Cardiology
Resource Allocation and Decision Making for Pediatric and Congenital Cardiac Catheterization During the (COVID-19 Pandemic
Resource Allocation and Decision Making for Pediatric and Congenital Cardiac Catheterization During the (COVID-19 Pandemic
04/08/2020

Brian H. Morray, MD1;  Brent M. Gordon, MD2;  Matthew A. Crystal, MD3;  Bryan H. Goldstein, MD4;  Athar M. Qureshi, MD5;  Alejandro J. Torres, MD3;  Shilpi M. Epstein, MD6;  Ivory Crittendon, MD7;  Frank F. Ing, MD8;  Shyam K. Sathanandam, MD9

Brian H. Morray, MD1;  Brent M. Gordo...
The novel coronavirus (COVID-19) pandemic has placed severe stress on healthcare systems around the world. There is limited information on current practices in pediatric cardiac catheterization laboratories in the United States. Our objective...
The novel coronavirus (COVID-19) pandemic has placed severe stress on healthcare systems around the world. There is limited information on current practices in pediatric cardiac catheterization laboratories in the United States. Our objective...
The novel coronavirus (COVID-19)...
04/08/2020
Journal of Invasive Cardiology
The First 4 Years of Postmarketing Safety Surveillance Related to the MitraClip Device: A United States Food and Drug Administration MAUDE Experience
The First 4 Years of Postmarketing Safety Surveillance Related to the MitraClip Device: A United States Food and Drug Administration MAUDE Experience
04/08/2020

Chetaj A. Mahabir, MBBS1*; Ersilia M. DeFilippis, MD2*; Sourabh Aggarwal, MD3; Anandbir Bath, MD4; Arman Qamar, MD5; Nilay K. Patel, MD6; Andrew M. Goldsweig, MD7; Muthiah Vaduganathan, MD, MPH5

Chetaj A. Mahabir, MBBS1*; Ersilia M....
Abstract: Objective. The MitraClip (Abbott) is a commercially available device to perform percutaneous transcatheter mitral valve repair (TMVR) for patients with symptomatic mitral regurgitation (MR). Recent data support its role in...
Abstract: Objective. The MitraClip (Abbott) is a commercially available device to perform percutaneous transcatheter mitral valve repair (TMVR) for patients with symptomatic mitral regurgitation (MR). Recent data support its role in...
Abstract: Objective. The...
04/08/2020
Journal of Invasive Cardiology

Column

Randomized Trial of Radial Hemostasis Using Focused vs Balloon Compression Devices
Cath Lab Management
Randomized Trial of Radial Hemostasis Using Focused vs Balloon Compression Devices
04/23/2020

Jordan G. Safirstein, MD1;  Ali Elfandi, MD1;  Nicole Reid, MD1;  Timothy W.I. Clark, MD2

Jordan G. Safirstein, MD1;  Ali Elfan...
Radial artery hemostasis devices differ in compression mechanisms, which may influence time to hemostasis and hand perfusion.
Radial artery hemostasis devices differ in compression mechanisms, which may influence time to hemostasis and hand perfusion.
Radial artery hemostasis devices...
04/23/2020
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

May 2020 Volume 32 Issue 5

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement